Incyte Corporation (Nasdaq:INCY) announced today it will participate in
the Goldman Sachs 30th Annual Global Healthcare Conference on
Tuesday, June 9, 2009 at 10:45 a.m. (Eastern Time). Presenting for
Incyte Corporation will be Paul Friedman, M.D., president and chief
executive officer.
The presentation will be webcast live and can be accessed at www.incyte.com
under Investor Relations, Events and Webcasts. A replay of the
presentation will be available for 180 days. Investors interested in
listening to the live webcast should log on before the start time in
order to download any software required.
Incyte Corporation is a Wilmington, Delaware-based drug discovery and
development company focused on developing proprietary small molecule
drugs to treat serious unmet medical needs. Incyte's pipeline includes
multiple compounds in Phase II clinical trials for oncology,
inflammation and diabetes. For additional information on Incyte, visit
the Company's web site at www.incyte.com.